Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
483 | 15640 | 46.4 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
304 | 3 | P53//RETINOBLASTOMA//MDM2 | 40663 |
483 | 2 | CYCLIN DEPENDENT KINASE//CELL CYCLE//CDK5 | 15640 |
2300 | 1 | E2F//P107//E2F1 | 2289 |
2551 | 1 | MPF//CDC2//GREATWALL | 2210 |
4549 | 1 | P16//CDKN2A//P16INK4A | 1767 |
5472 | 1 | CYCLIN D1//CCND1//CYCLIN D3 | 1619 |
5545 | 1 | SKP2//P27KIP1//P27 | 1608 |
7118 | 1 | FLAVOPIRIDOL//CYCLIN DEPENDENT KINASE//ROSCOVITINE | 1403 |
9064 | 1 | P21//P21WAF1 CIP1//P21WAF1 | 1190 |
11551 | 1 | CDK5//P35//CYCLIN DEPENDENT KINASE 5 | 973 |
15937 | 1 | CDC25B//CDC25 PHOSPHATASE//CDC25A | 683 |
16420 | 1 | PEDIAT CHILDREN SURG//SOMATIC GENOME VARIATIONS//CELL CYCLE RE ENTRY | 654 |
16686 | 1 | CYCLIN E//CYCLIN A1//CYCLIN B1 | 641 |
23606 | 1 | CAK//SPY1//CDK ACTIVATING KINASE | 340 |
34552 | 1 | CCNG2//CYCLIN G2//CYCLIN G | 110 |
36554 | 1 | CDK2AP1//P12CDK2 AP1//DOC 1 | 79 |
36779 | 1 | CDK11P58//PITSLRE//CDK11 | 74 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CYCLIN DEPENDENT KINASE | authKW | 430625 | 3% | 44% | 504 |
2 | CELL CYCLE | authKW | 426260 | 12% | 11% | 1948 |
3 | CDK5 | authKW | 311847 | 2% | 58% | 278 |
4 | CYCLIN D1 | authKW | 287532 | 4% | 25% | 594 |
5 | E2F | authKW | 281597 | 2% | 48% | 302 |
6 | CYCLIN | authKW | 245151 | 3% | 30% | 415 |
7 | P27KIP1 | authKW | 242899 | 2% | 36% | 343 |
8 | P27 | authKW | 233595 | 2% | 34% | 349 |
9 | SKP2 | authKW | 189725 | 1% | 61% | 160 |
10 | CDK | authKW | 169534 | 1% | 40% | 215 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 64574 | 33% | 1% | 5236 |
2 | Oncology | 56105 | 32% | 1% | 4983 |
3 | Biochemistry & Molecular Biology | 19997 | 32% | 0% | 5015 |
4 | Genetics & Heredity | 9049 | 11% | 0% | 1756 |
5 | Developmental Biology | 7110 | 5% | 1% | 725 |
6 | Pathology | 2236 | 4% | 0% | 636 |
7 | Biophysics | 758 | 4% | 0% | 574 |
8 | Reproductive Biology | 741 | 2% | 0% | 267 |
9 | Medicine, Research & Experimental | 527 | 3% | 0% | 532 |
10 | Chemistry, Medicinal | 527 | 3% | 0% | 394 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELL CYCLE REGULAT GRP | 38384 | 0% | 62% | 32 |
2 | PATHOL | 14478 | 12% | 0% | 1937 |
3 | SBARRO CANC MOL MED | 14419 | 0% | 11% | 65 |
4 | MOLEC BIOL MB7 | 13653 | 0% | 100% | 7 |
5 | DTP CLIN TRIALS UNIT | 11945 | 0% | 88% | 7 |
6 | MOL THER EUT UNIT | 11758 | 0% | 46% | 13 |
7 | TUMOR CELL BIOL | 11226 | 0% | 8% | 69 |
8 | CANC | 10829 | 4% | 1% | 656 |
9 | FUNCT GENOM SECT | 10332 | 0% | 25% | 21 |
10 | VECTOROL EXPT GENE THER Y | 10186 | 0% | 35% | 15 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOGENE | 68294 | 5% | 4% | 800 |
2 | COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY SERIES | 38556 | 2% | 6% | 314 |
3 | MOLECULAR AND CELLULAR BIOLOGY | 15482 | 3% | 2% | 429 |
4 | CANCER RESEARCH | 12037 | 3% | 1% | 506 |
5 | CELL GROWTH & DIFFERENTIATION | 7869 | 0% | 5% | 76 |
6 | CLINICAL CANCER RESEARCH | 7234 | 2% | 2% | 241 |
7 | GENES & DEVELOPMENT | 6190 | 1% | 2% | 157 |
8 | INTERNATIONAL JOURNAL OF ONCOLOGY | 6043 | 1% | 2% | 176 |
9 | MOLECULAR AND CELLULAR DIFFERENTIATION | 5664 | 0% | 36% | 8 |
10 | CELL DIVISION | 5411 | 0% | 12% | 24 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYCLIN DEPENDENT KINASE | 430625 | 3% | 44% | 504 | Search CYCLIN+DEPENDENT+KINASE | Search CYCLIN+DEPENDENT+KINASE |
2 | CELL CYCLE | 426260 | 12% | 11% | 1948 | Search CELL+CYCLE | Search CELL+CYCLE |
3 | CDK5 | 311847 | 2% | 58% | 278 | Search CDK5 | Search CDK5 |
4 | CYCLIN D1 | 287532 | 4% | 25% | 594 | Search CYCLIN+D1 | Search CYCLIN+D1 |
5 | E2F | 281597 | 2% | 48% | 302 | Search E2F | Search E2F |
6 | CYCLIN | 245151 | 3% | 30% | 415 | Search CYCLIN | Search CYCLIN |
7 | P27KIP1 | 242899 | 2% | 36% | 343 | Search P27KIP1 | Search P27KIP1 |
8 | P27 | 233595 | 2% | 34% | 349 | Search P27 | Search P27 |
9 | SKP2 | 189725 | 1% | 61% | 160 | Search SKP2 | Search SKP2 |
10 | CDK | 169534 | 1% | 40% | 215 | Search CDK | Search CDK |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RUAS, M , PETERS, G , (1998) THE P16(INK4A)/CDKN2A TUMOR SUPPRESSOR AND ITS RELATIVES.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1378. ISSUE 2. P. F115 -F177 | 382 | 72% | 528 |
2 | DYSON, N , (1998) THE REGULATION OF E2F BY PRB-FAMILY PROTEINS.GENES & DEVELOPMENT. VOL. 12. ISSUE 15. P. 2245-2262 | 161 | 88% | 1660 |
3 | ASGHAR, U , WITKIEWICZ, AK , TURNER, NC , KNUDSEN, ES , (2015) THE HISTORY AND FUTURE OF TARGETING CYCLIN-DEPENDENT KINASES IN CANCER THERAPY.NATURE REVIEWS DRUG DISCOVERY. VOL. 14. ISSUE 2. P. 130 -146 | 131 | 74% | 97 |
4 | SHERR, CJ , (1996) CANCER CELL CYCLES.SCIENCE. VOL. 274. ISSUE 5293. P. 1672 -1677 | 120 | 67% | 4122 |
5 | DIMOVA, DK , DYSON, NJ , (2005) THE E2F TRANSCRIPTIONAL NETWORK: OLD ACQUAINTANCES WITH NEW FACES.ONCOGENE. VOL. 24. ISSUE 17. P. 2810-2826 | 169 | 79% | 396 |
6 | SHAPIRO, GI , (2006) CYCLIN-DEPENDENT KINASE PATHWAYS AS TARGETS FOR CANCER TREATMENT.JOURNAL OF CLINICAL ONCOLOGY. VOL. 24. ISSUE 11. P. 1770-1783 | 145 | 78% | 524 |
7 | CHU, IM , HENGST, L , SLINGERLAND, JM , (2008) THE CDK INHIBITOR P27 IN HUMAN CANCER: PROGNOSTIC POTENTIAL AND RELEVANCE TO ANTICANCER THERAPY.NATURE REVIEWS CANCER. VOL. 8. ISSUE 4. P. 253 -267 | 136 | 68% | 472 |
8 | MOLLER, MB , (2003) MOLECULAR CONTROL OF THE CELL CYCLE IN CANCER: BIOLOGICAL AND CLINICAL ASPECTS.DANISH MEDICAL BULLETIN. VOL. 50. ISSUE 2. P. 118-138 | 317 | 60% | 18 |
9 | DEGREGORI, J , JOHNSON, DG , (2006) DISTINCT AND OVERLAPPING ROLES FOR E2F FAMILY MEMBERS IN TRANSCRIPTION, PROLIFERATION AND APOPTOSIS.CURRENT MOLECULAR MEDICINE. VOL. 6. ISSUE 7. P. 739-748 | 154 | 80% | 262 |
10 | MUSGROVE, EA , CALDON, CE , BARRACLOUGH, J , STONE, A , SUTHERLAND, RL , (2011) CYCLIN D AS A THERAPEUTIC TARGET IN CANCER.NATURE REVIEWS CANCER. VOL. 11. ISSUE 8. P. 558 -572 | 118 | 65% | 381 |
Classes with closest relation at Level 2 |
Rank | Class id | link |
---|---|---|
1 | 2853 | RETINOBLASTOMA//OPHTHALM ONCOL SERV//CHEMOREDUCTION |
2 | 2913 | CELLULAR SENESCENCE//SENESCENCE//ST PETERSBURG BIOREGULAT GERONTOL |
3 | 2346 | EGG ACTIVATION//OOCYTE ACTIVATION//SPERM FACTOR |
4 | 2682 | DNA REPLICATION//GEMININ//CDC6 |
5 | 936 | P53//MDM2//P73 |
6 | 2754 | MYC//MAX//C MYC |
7 | 540 | KINETOCHORE//MITOSIS//CENTROSOME |
8 | 1195 | JNK//ERK5//MAP KINASE |
9 | 3037 | KLF4//KRUPPEL LIKE FACTOR//GADD45 |
10 | 3108 | FOXM1//FOXO1//FOXO |